**Title: Trump Cuts WHO Funding While Boosting Gavi Vaccine Alliance Support**
**Date: July 30, 2026**
In a significant shift in international health funding, the United States has announced a $600 million allocation for Gavi, the Vaccine Alliance, while simultaneously cutting off financial support to the World Health Organization (WHO). This decision represents a major financial setback for the WHO, which has faced scrutiny from the Trump administration.
The announcement was made through a joint statement from the U.S. Department of State and the Department of Health and Human Services. The statement emphasized that the U.S. will no longer provide government funding to the WHO via Gavi, marking a continuation of the Trump administration's critical stance towards the UN agency.
President Donald Trump instructed Health and Human Services Secretary Robert Kennedy Jr. and Secretary of State Marco Rubio to negotiate reforms with Gavi as a prerequisite for any renewed U.S. support. This directive aligns with Trump's long-standing criticisms of the WHO, particularly regarding its handling of the COVID-19 pandemic.
In 2020, Trump halted U.S. funding to the WHO, alleging that the organization had facilitated the spread of misinformation from China, which he claimed contributed to the global outbreak of the virus. At that time, the U.S. was the largest donor to the WHO, contributing over $400 million, which accounted for approximately 15% of the organization's budget.
Following Trump's departure from office, President Joe Biden reversed the funding cuts and reinstated U.S. contributions to the WHO. However, upon his return to the presidency in January 2025, Trump announced that the U.S. would withdraw from the WHO and suspend its contributions once again.
Republican Senator Susan Collins expressed support for the recent decision to allocate funds to Gavi, emphasizing the importance of the global vaccination initiative. Gavi has committed to working towards replacing mercury-containing vaccines with mercury-free alternatives, collaborating with its board and partner nations to enhance vaccine safety.
The WHO, which operates on a budget of approximately $3.4 billion, relies on a mix of core funding from member states and voluntary contributions from various partners. Its budget is significantly smaller than that of the Centers for Disease Control and Prevention (CDC), which received $9.3 billion in funding for 2023.
The WHO plays a crucial role in global health, funding programs aimed at preventing and treating diseases such as polio, tuberculosis, HIV, malaria, and measles, particularly in low-income countries that struggle to provide adequate healthcare. Additionally, the organization responds to health emergencies in conflict zones, including regions like Gaza, Sudan, and the Democratic Republic of the Congo.
Experts have noted that the Trump administration's decisions regarding the WHO appear to be driven more by ideological beliefs than by strategic considerations. The implications of cutting off funding to the WHO could have far-reaching effects on global health initiatives and the organization's ability to respond to health crises.
As the U.S. shifts its focus towards Gavi, the long-term impact of these funding changes on both the WHO and global vaccination efforts remains to be seen. The international community continues to monitor the situation closely, as the dynamics of global health funding evolve amidst ongoing challenges posed by infectious diseases and health emergencies worldwide.